Innovaderm manages a study in PPP and beats recruitment timelines
Aristea recently published Phase 2a clinical data in Dermatology and Therapy from its study managed by Innovaderm Research, highlighting the safety and potential efficacy of Aristeaâs lead program RIST4721 for the treatment of moderate to severe palmoplantar pustulosis (PPP). This study came with its challenges from Day 1: It was a study being conducted in […]
Indero, a Key Collaborator in Clinical and Study Development for Recently Published Phase 1 Atopic Dermatitis Study
Allergy recently published RAPT Therapeuticsâ phase 1a/1b atopic dermatitis (AD) study, in which Innovaderm Research was a key partner, serving as the contract research organization (CRO). This was a first-in-human and proof of concept randomized, placebo-controlled Phase 1a/1b monotherapy study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and CCR4 surface receptor occupancy of zelnecirnon (formerly RPT193) […]
Generalized Pustular Psoriasis (GPP) Rescue Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully transitioned this rescue study from another CRO and this resulted in: More than doubled patient enrollment in 1 month Started enrollment 1 month faster than initial projection All 5 newly added sites were actively recruiting Study Characteristics Study Phase: IIa Study Type: Rescue study […]
Hidradenitis Suppurativa (HS) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this HS study and this resulted in: Enrollment completed 3 months ahead of schedule Study Characteristics Study Phase: II Patient Population: Hidradenitis Suppurativa IP Route of Administration: Systemic – Subcutaneous Site distribution: 25 in North America and 16 in Europe Study Challenges […]
Palmoplantar Pustulosis (PPP) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this PPP study and this resulted in: Enrollment completed 3 weeks ahead of schedule; Successful study and satisfied sponsor Study Characteristics Study Phase: II Patient Population: Palmoplantar pustulosis IP Route of Administration: Systemic Sites Distribution: 17 sites in 2 countries (Canada, Germany) […]
Notalgia Paresthetica (NP) Case Study
Click here for a PDF version of this case study Study Characteristics Study Phase: II Patient Population: 126 patients with Notalgia Paresthetica (NP) (Pruritus associated with NP) IP Route of Administration: Systemic (oral) Site Distribution: 33 sites (USA and Canada) Study Procedures: Photographs, Pharmacokinetics, Electrocardiograms Study Challenges and Solutions Patient awareness: Challenge in advertisement as patients are […]
Alopecia Areata (AA) Case Study
Click here for a PDF version of this case study Outcomes Innovadermâs outstanding support on this alopecia areata study resulted in a rapid increase in enrollment rates and the successful management of this trial Study Characteristics Study Phase: II Patient Population: Alopecia Areata IP Route of Administration: Systemic Sites distribution: 12 sites (CAD-USA) Complex study procedures: […]
Atopic Dermatitis (AD) Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this AD study and this resulted in enrollment completed 2 months earlier than planned; Innovaderm CRU recruited 33% of patients Study Characteristics Study Phase: Ib Patient Population: 36 subjects with moderate to severe AD IP Route of Administration: Systemic – Oral Site […]
Acne Case Study
Click here for a PDF version of this case study Outcomes Innovaderm successfully managed this acne study and this resulted in enrollment completed 1 month earlier than planned Study Characteristics Study Phase: II Patient Population: Acne vulgaris (enrolling pediatrics & adults) IP Route of Administration: Systemic Sites distribution: 15 sites (USA) Study Challenges and Solutions Challenge […]
